Pay in 4 interest-free payments of $5.70 Learn more
Ships within 48 hours · Estimated delivery Nov 1 - Nov 6
LEADER, SUSTAIN-6, and REWIND trial outcomes The initial wave of cardiovascular outcome trials (CVOTs) predominantly focused on patients with type 2 diabetes at elevated cardiovascular risk
About the author Cassie McGrath Cassie McGrath is a reporter at Healthcare Brew, where she focuses on the inner-workings and business of hospitals, unions, policy, and how AI is impacting the industry.
He also continues to see his therapist regularly
Mullins PG
US$ 23.82
US$ 29.97
US$ 23.85
